Xing Cheng

Title: Xing Cheng - Innovator in Coronavirus Detection

Introduction

Xing Cheng is an inventor based in Changsha, China. He is currently associated with Sansure Biotech Inc. His work primarily focuses on developing innovative solutions for detecting and typing coronaviruses and other respiratory viruses. Although he has not yet been granted any patents, his contributions to the field are noteworthy.

Latest Patent Applications

Xing Cheng has filed several significant patent applications, including:

1. **COMPOSITION, KIT, AND METHOD FOR DETECTING AND TYPING CORONAVIRUSES** - This invention provides a composition capable of detecting and typing various coronaviruses, including novel coronavirus 2019-nCoV, coronavirus 229E, coronavirus NL63, coronavirus OC43, coronavirus HKU1, coronavirus MERSr-CoV, and coronavirus SARSr-CoV. The kit comprises the composition and utilizes a fluorescent probe method and a melting curve method for simultaneous detection and typing of seven coronaviruses in one tube.

2. **COMPOSITION, KIT AND METHOD FOR DETECTING AND TYPING VIRUSES CAUSING RESPIRATORY TRACT INFECTION AND APPLICATION OF COMPOSITION, KIT AND METHOD** - This application presents a composition for detecting novel coronavirus, influenza A virus, and influenza B virus. It also includes a kit with the composition and a method for detecting and typing viruses that cause respiratory tract infections.

Conclusion

Xing Cheng is making significant strides in the field of virus detection, particularly in relation to coronaviruses. His innovative applications demonstrate a commitment to advancing medical technology and public health.